CDK4 and non-small cell lung carcinoma: In addition, combining CDK4/6 inhibitors with chemotherapy and radiotherapy was more beneficial to OS than treatment with CDK4/6 or radiation alone in mouse models of AT/RTs, glioblastoma, and non-small cell lung cancer [16,18,22].